Send me a link:

*Text messaging rates may apply.

 Dow Down0.13% Nasdaq Up0.20%

More On DIVISLAB.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Divi's Laboratories Limited (DIVISLAB.NS)

-NSE
1,474.20 Down 2.55(0.17%) 5:59AM EDT
ProfileGet Profile for:
Divi's Laboratories Limited
7-1-77/E/1/303, Divi Towers
Dharam Karan Road
Hyderabad, 500016
India - Map
Phone: 91 40 2378 6300
Fax: 91 40 2378 6460
Website: http://www.divislabs.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:N/A

Business Summary 

Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin, canthaxanthin, etc.; neutraceuticals; protected amino acids comprising BOC, FMOC, and CBZ; and novel ligands, including binol and binap. The company also offers custom synthesis of API and advanced intermediates for discovery compounds to pharma companies. It also exports its products primarily to European and the American countries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Divi's Laboratories Limited

Key Executives 
 PayExercised
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D., 63
Chairman and Managing Director
264.57MN/A
Mr. L. Kishore Babu B.Com, FICWA, FCMA, 62
Chief Financial Officer and Member of Shareholders/Investors Grievance Committee
N/AN/A
Mr. Kiran S. Divi B. Pharm., 38
Pres of Operations, Director of Operations, Exec. Director and Member of Allotment Committee
94.54MN/A
Mr. L. Ramesh Babu M.Com, MBA, LLB, 57
Chief Information Officer
N/AN/A
Mr. Venkata Ramana Nandimpalli B.Sc.(Chem), 57
Exec. Director and Member of Shareholders/Investors Grievance Committee
137.12MN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.